Literature DB >> 13961286

The toxic effects of amphotericin B in man.

C W HOLEMAN, H EINSTEIN.   

Abstract

Studies of 47 patients with intravenous amphotericin B revealed some impairment of renal function in all cases. Azotemia developed in 46 cases. Microscopic examination in eight cases showed damage to the distal renal tubule. Profound hypokalemia was recognized in two cases; and symptoms suggesting hypokalemia, which were generally ameliorated by potassium administration, were noted in most cases. It is postulated that the initial potassium loss is due to a "tubular leak" and that subsequent potassium depletion leads to further tubular damage. Mild to severe anemia developed in all cases during therapy. Serial red cell indices, bone marrow examinations and red cell survival studies indicated that hemolysis, rather than bone marrow depression, was responsible.The decision to treat, to modify therapy or to terminate treatment must be made on the basis of severity of disease, probability of progression, and renal status.

Entities:  

Keywords:  AMPHOTERICIN B; ANEMIA, HEMOLYTIC; HYPOKALEMIA; KIDNEY TUBULES

Mesh:

Substances:

Year:  1963        PMID: 13961286      PMCID: PMC1515233     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  9 in total

1.  On the nephrotoxicity of amphotericin B in man.

Authors:  N H BELL; V T ANDRIOLE; S M SABESIN; J P UTZ
Journal:  Am J Med       Date:  1962-07       Impact factor: 4.965

2.  The use of amphotericin B in man.

Authors:  V T ANDRIOLE; H M KRAVETZ
Journal:  JAMA       Date:  1962-04-28       Impact factor: 56.272

3.  The use of amphotericin B in the treatment of coccidioidal disease.

Authors:  W A WINN
Journal:  Am J Med       Date:  1959-10       Impact factor: 4.965

4.  Anatomy of body water and electrolytes.

Authors:  I S EDELMAN; J LEIBMAN
Journal:  Am J Med       Date:  1959-08       Impact factor: 4.965

5.  Coccidioidomycosis and its treatment with amphotericin B.

Authors:  M L LITTMAN; P L HOROWITZ; J G SWADEY
Journal:  Am J Med       Date:  1958-04       Impact factor: 4.965

6.  The nephropathy of potassium depletion; a clinical and pathological entity.

Authors:  A S RELMAN; W B SCHWARTZ
Journal:  N Engl J Med       Date:  1956-08-02       Impact factor: 91.245

7.  Low potassium syndrome due to defective renal tubular mechanisms for handling potassium.

Authors:  D P EARLE; S SHERRY; L W EICHNA; N J CONAN
Journal:  Am J Med       Date:  1951-09       Impact factor: 4.965

8.  A therapeutic dilemma. The treatment of disseminated coccidioidomycosis with amphotericin B.

Authors:  W G SANFORD; J R RASCH; R B STONEHILL
Journal:  Ann Intern Med       Date:  1962-04       Impact factor: 25.391

9.  Coccidioidal meningitis. The use of amphotericin B in treatment.

Authors:  H E EINSTEIN; C W HOLEMAN; L L SANDIDGE; D H HOLDEN
Journal:  Calif Med       Date:  1961-06
  9 in total
  8 in total

1.  Role of phosphatidylserine synthase in shaping the phospholipidome of Candida albicans.

Authors:  Chelsi D Cassilly; Abigail T Farmer; Anthony E Montedonico; Terry K Smith; Shawn R Campagna; Todd B Reynolds
Journal:  FEMS Yeast Res       Date:  2017-03-01       Impact factor: 2.796

2.  Oral amphotericin B in the treatment of ulcerative intestinal diseases.

Authors:  M Z Sait; K G Rajagopal; F Villa; F Steigmann
Journal:  Am J Dig Dis       Date:  1970-11

Review 3.  Amphotericin B nephrotoxicity.

Authors:  R Sabra; R A Branch
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

4.  Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys.

Authors:  W E Bullock; R G Luke; C E Nuttall; D Bhathena
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  Erythropoietin concentration in amphotericin B-induced anemia.

Authors:  R R MacGregor; J E Bennett; A J Erslev
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

6.  THE TREATMENT OF COCCIDIOIDAL MENINGITIS. THE USE OF AMPHOTERICIN B IN A GROUP OF 25 PATIENTS.

Authors:  W A WINN
Journal:  Calif Med       Date:  1964-08

7.  Mapping the Substrate-Binding Sites in the Phosphatidylserine Synthase in Candida albicans.

Authors:  Yue Zhou; Chelsi D Cassilly; Todd B Reynolds
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

8.  SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A.

Authors:  Chelsi D Cassilly; Marcus M Maddox; Philip T Cherian; John J Bowling; Mark T Hamann; Richard E Lee; Todd B Reynolds
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.